Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials.

Asian countries cost effectiveness discount rate economic evaluation health behavior interventions type 2 diabetes mellitus

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
30 08 2022
Historique:
received: 28 06 2022
revised: 25 08 2022
accepted: 26 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

Health behavior interventions implemented in Asian countries often lack economic evaluations that effectively address the problems of type 2 diabetes mellitus. This review systematically assessed the existing literature on economic evaluation of health behavior interventions to prevent and manage type 2 diabetes mellitus for people living in Asian countries. Eligible studies were identified through a search of six bibliographic databases, namely, PubMed, Scopus, Public Health Database by ProQuest, Cumulative Index to Nursing and Allied Health Literature Complete, Web of Science, and Google Scholar. Randomized controlled trials of health behavior interventions and studies published in the English language from January 2000 to May 2022 were included in the review. The search yielded 3867 records, of which 11 studies were included in the review. All included studies concluded that health behavior interventions were cost-effective. Eight of these studies undertook an evaluation from a health system perspective, two studies used both societal and health system perspectives, and one study utilized a societal and multi-payer perspective. This review identified the time horizon, direct and indirect medical costs, and discount rates as the most important considerations in determining cost effectiveness. These findings have implications in extending health behavior interventions to prevent and manage type 2 diabetes mellitus in low-resource settings, and are likely to yield the most promising outcomes for people with type 2 diabetes mellitus.

Identifiants

pubmed: 36078539
pii: ijerph191710799
doi: 10.3390/ijerph191710799
pmc: PMC9518060
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Bull World Health Organ. 2016 Dec 1;94(12):925-930
pubmed: 27994285
BMJ. 1996 Aug 3;313(7052):275-83
pubmed: 8704542
Bull World Health Organ. 2015 Feb 1;93(2):118-24
pubmed: 25883405
JAMA Netw Open. 2020 Jul 1;3(7):e207539
pubmed: 32725244
PLoS One. 2020 Dec 31;15(12):e0242962
pubmed: 33382746
BMJ. 2013 Mar 25;346:f1049
pubmed: 23529982
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211029816
pubmed: 34236004
J Clin Pharm Ther. 2018 Dec;43(6):775-783
pubmed: 29696669
Value Health. 2019 Mar;22(3):377-382
pubmed: 30832977
Diabetes Care. 2007 Oct;30(10):2548-52
pubmed: 17670917
BMC Med. 2020 Sep 4;18(1):251
pubmed: 32883279
Cost Eff Resour Alloc. 2020 Oct 23;18:47
pubmed: 33110399
BMC Public Health. 2013 Aug 07;13:729
pubmed: 23919839
J Diabetes Res. 2020 Apr 13;2020:7410797
pubmed: 32352016
Diabetes Res Clin Pract. 2020 Apr;162:108072
pubmed: 32061820
Int J Technol Assess Health Care. 2011 Oct;27(4):275-82
pubmed: 22004767
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
PLoS One. 2021 Nov 18;16(11):e0260139
pubmed: 34793562
Diabetes Care. 2009 Aug;32(8):1453-8
pubmed: 19435958
Bull World Health Organ. 2017 Aug 1;95(8):550-551
pubmed: 28804165
Cardiovasc Diabetol. 2020 Oct 20;19(1):182
pubmed: 33081808
PLoS One. 2014 Sep 09;9(9):e107225
pubmed: 25203633
Med Sci Monit. 2006 Jul;12(7):RA130-47
pubmed: 16810145
Global Health. 2015 Jun 04;11:23
pubmed: 26040275
Ann Intern Med. 2015 Sep 15;163(6):452-60
pubmed: 26167962
Diabetes Care. 2015 Jan;38 Suppl:S8-S16
pubmed: 25537714
Int J Endocrinol. 2021 Jul 01;2021:8827629
pubmed: 34306072
J Med Econ. 2021 Jan-Dec;24(1):730-740
pubmed: 33989086
Diabetes Care. 2018 May;41(5):963-970
pubmed: 29475843
Iran J Nurs Midwifery Res. 2019 May-Jun;24(3):206-212
pubmed: 31057637
Diabetes Care. 2016 Mar;39(3):472-85
pubmed: 26908931
Sci Rep. 2020 Sep 8;10(1):14790
pubmed: 32901098
J Diabetes Res. 2016;2016:2159890
pubmed: 26885527
Diabetes Care. 2020 Jul;43(7):1593-1616
pubmed: 33534726
Am J Prev Med. 2015 Mar;48(3):271-80
pubmed: 25498548
Public Health. 2018 Oct;163:141-152
pubmed: 30193174
J Diabetes Res. 2016;2016:1219581
pubmed: 26798647
Health Aff (Millwood). 2012 Jan;31(1):67-75
pubmed: 22232096
Circulation. 2021 Dec 14;144(24):e495-e514
pubmed: 34689589
Med Clin North Am. 2011 Mar;95(2):373-84, viii
pubmed: 21281839
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
Diabetes Obes Metab. 2017 Sep;19(9):1312-1316
pubmed: 28230312
BMJ Open. 2017 Nov 15;7(11):e017184
pubmed: 29146638
Int J Technol Assess Health Care. 2005 Spring;21(2):240-5
pubmed: 15921065
Value Health. 2013 Mar-Apr;16(2):231-50
pubmed: 23538175
Value Health. 2018 Jul;21(7):759-761
pubmed: 30005746
Diabetes Obes Metab. 2019 Jan;21(1):73-83
pubmed: 30058268
Diabetes Care. 2020 Jul;43(7):1557-1592
pubmed: 33534729
BMJ Open. 2018 Apr 3;8(4):e017809
pubmed: 29615442
Diabetes Care. 2010 Aug;33(8):1872-94
pubmed: 20668156
Pharmacoecon Open. 2021 Dec;5(4):693-700
pubmed: 34254276
Curr Diab Rep. 2019 May 16;19(6):34
pubmed: 31098775

Auteurs

Padam Kanta Dahal (PK)

School of Health, Medical and Applied Sciences, Central Queensland University, Sydney, NSW 2000, Australia.
Appleton Institute, Physical Activity Research Group, Central Queensland University, Rockhampton, QLD 4702, Australia.

Lal B Rawal (LB)

School of Health, Medical and Applied Sciences, Central Queensland University, Sydney, NSW 2000, Australia.
Appleton Institute, Physical Activity Research Group, Central Queensland University, Rockhampton, QLD 4702, Australia.
Translational Health Research Institute (THRI), Western Sydney University, Sydney, NSW 2751, Australia.

Rashidul Alam Mahumud (RA)

NHRMC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.

Grish Paudel (G)

School of Health, Medical and Applied Sciences, Central Queensland University, Sydney, NSW 2000, Australia.
Appleton Institute, Physical Activity Research Group, Central Queensland University, Rockhampton, QLD 4702, Australia.

Tomohiko Sugishita (T)

Section of Global Health, Division of Public Health, Department of Public Health, Tokyo Women's Medical University, Tokyo 162-8666, Japan.

Corneel Vandelanotte (C)

Appleton Institute, Physical Activity Research Group, Central Queensland University, Rockhampton, QLD 4702, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH